90 related articles for article (PubMed ID: 21695985)
1. [The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases].
Krivolapov IuA; Peshkov MV; Leenman EE; Matsionis AE; Kovrigina AM
Arkh Patol; 2011; 73(2):25-32. PubMed ID: 21695985
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
3. Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study.
Torlakovic EE; Naresh K; Kremer M; van der Walt J; Hyjek E; Porwit A
J Clin Pathol; 2009 Jun; 62(6):547-51. PubMed ID: 19474355
[TBL] [Abstract][Full Text] [Related]
4. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
5. [The importance of immunohistochemical examination in the diagnosis of malignant lymphoproliferative diseases--the author's personal experience].
Căruntu ID
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):129-33. PubMed ID: 10756784
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
8. An approach to practical problems in the diagnosis of lymphoproliferative disorders using cytochemistry and immunocytochemistry.
Beckstead JH
Clin Lab Med; 1988 Mar; 8(1):211-22. PubMed ID: 3282760
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoid hyperplasia of the palate: case report and literature review.
Jham BC; Binmadi NO; Scheper MA; Zhao XF; Koterwas GE; Kashyap A; Levy BA
J Craniomaxillofac Surg; 2009 Mar; 37(2):79-82. PubMed ID: 19138528
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
11. A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry.
Warnke R; Pederson M; Williams C; Levy R
Am J Clin Pathol; 1978 Dec; 70(6):67-75. PubMed ID: 103428
[TBL] [Abstract][Full Text] [Related]
12. High-throughput immunophenotyping of 43 ferret lymphomas using tissue microarray technology.
Hammer AS; Williams B; Dietz HH; Hamilton-Dutoit SJ
Vet Pathol; 2007 Mar; 44(2):196-203. PubMed ID: 17317796
[TBL] [Abstract][Full Text] [Related]
13. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W
J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
[TBL] [Abstract][Full Text] [Related]
14. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
15. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens].
Frank GA; Kaplanskaia IB; Glasko EN; Semenov EA; Roshchina LS; Korolev AV
Arkh Patol; 2007; 69(3):15-8. PubMed ID: 17722588
[TBL] [Abstract][Full Text] [Related]
18. An interlaboratory comparison of immunohistochemistry and PCR methods for detection of Neospora caninum in bovine foetal tissues.
van Maanen C; Wouda W; Schares G; von Blumröder D; Conraths FJ; Norton R; Williams DJ; Esteban-Redondo I; Innes EA; Mattsson JG; Björkman C; Fernández-García A; Ortega-Mora LM; Müller N; Sager H; Hemphill A
Vet Parasitol; 2004 Dec; 126(4):351-64. PubMed ID: 15567040
[TBL] [Abstract][Full Text] [Related]
19. [Histologic diagnosis of lymphoproliferative diseases of the digestive tract].
Ozzello L; Saraga EP; Hurlimann J
Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1037-41. PubMed ID: 7423144
[TBL] [Abstract][Full Text] [Related]
20. Nordic immunohistochemical quality control.
Vyberg M; Torlakovic E; Seidal T; Risberg B; Helin H; Nielsen S
Croat Med J; 2005 Jun; 46(3):368-71. PubMed ID: 15861513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
